Please login to the form below

Not currently logged in
Email:
Password:

Encysive launches Thelin for hypertension in Spain

US-based Encysive Pharmaceuticals has launched Thelin (sitaxentan) 100 mg tablets in Spain for the treatment of pulmonary arterial hypertension (PAH).

US-based Encysive Pharmaceuticals has launched Thelin (sitaxentan) 100 mg tablets in Spain for the treatment of pulmonary arterial hypertension (PAH).

Encysive won EU marketing authorisation for the product from the EU Commission in August 2006.

Thelin is the first marketed selective endothelin A receptor antagonist, and the first once-daily oral treatment available for patients with PAH. Encysive will sell the product through its Spanish marketing partner, Praxis Pharmaceutical.

Thelin is indicated for improving exercise capacity in PAH patients classified as World Health Organisation (WHO) functional class III. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease (CTD).

Encysive will successively launch Thelin in all 27 member states of the EU, as local government approval for reimbursement is obtained, says the firm.

George Cole, Encysive's CEO, said: "Through our marketing partnership with Praxis, we are able to immediately begin selling THELIN in Spain without the need to invest in a dedicated sales and marketing infrastructure."

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics